Purdue Pharma and owners to pay $7.4B in settlement over OxyContin’s toll
The deal represents an increase of more than $1 billion over a previous settlement deal that was rejected last year by the U.S. Supreme Court.
Pharmaceuticals
Articles
Indiana attorney general sues drug companies over EpiPen prices
The 107-page lawsuit claims Mylan and Pfizer conspired to increase EpiPen’s price by more than 600% and prevented similar products from coming to market. Pfizer denied the allegations. Mylan did not immediately respond to a request for comment.
Walgreens to pay $106M to settle allegations it submitted false payment claims for prescriptions
Walgreens has agreed to pay $106 million to settle lawsuits that alleged the pharmacy chain submitted false payment claims with government health care programs for prescriptions that were never dispensed.
The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma
The Supreme Court on Thursday rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from civil lawsuits over the toll of opioids but also would have provided billions of dollars to combat the opioid epidemic.
OxyContin marketer agrees to pay $350M rather than face lawsuits
An advertising agency that helped develop marketing campaigns for OxyContin and other prescription painkillers has agreed to pay U.S. states $350 million rather than face the possibility of trials over its role in the opioid crisis.
Nevada company sues Lilly for breach of contract over Alzheimer’s drug
A Nevada-based biotech company is suing Eli Lilly and Co., saying the Indianapolis-based drugmaker is refusing to pay royalties on patented technology it claims is used in Lilly’s pending new treatment for Alzheimer’s disease.
OxyContin maker’s settlement plan divides victims of opioid crisis. Now it’s up to the Supreme Court
The agreement by the maker of OxyContin to settle thousands of lawsuits over the harm done by opioids could help combat the overdose epidemic that the painkiller helped spark. But that does not mean all the victims are satisfied.
Judge overturns $176.5M jury verdict against Lilly in patent infringement suit
A federal judge has overturned a $176.5 million jury verdict against Eli Lilly and Co., finding that the Indianapolis-based drugmaker did not infringe on the patents of a competitor in developing a treatment for migraine headaches.
Lilly files lawsuits over unauthorized versions of Mounjaro
Eli Lilly and Co. has filed lawsuits against 10 companies it accuses of selling unauthorized versions of its diabetes drug Mounjaro, Bloomberg News reported Tuesday.
Lilly, Novo Nordisk sued for alleged failure to warn about ‘severe’ side effects of popular diabetes drugs
Eli Lilly and Co. and the maker of diabetes drug Ozempic are being sued in federal court in Louisiana for allegedly failing to warn consumers and physicians about the risk of “severe gastrointestinal events” resulting from the use of two diabetes drugs.
Supreme Court revives claims that SuperValu, Safeway overcharged governments for generic drugs
The Supreme Court on Thursday unanimously revived whistleblower lawsuits claiming that supermarket and pharmacy chains SuperValu and Safeway overcharged government health care programs for prescription drugs by hundreds of millions of dollars.
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits
A federal court ruling cleared the way Tuesday for OxyContin maker Purdue Pharma’s settlement of thousands of legal claims over the toll of opioids.
COA overturns attorney fees award in dispute between ex-pharmacist, Pharmacy Board
A pharmacist convicted of producing and distributing adulterated drugs was not entitled to attorney fees in his case against the Indiana Board of Pharmacy, which was entitled to immunity, the Court of Appeals of Indiana has ruled.
FDA approves over-the-counter Narcan. Here’s what it means
The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter.
Indiana to get $66.5M to settle overpayment suit against insurer Centene
Indiana has reached a $66.5 million settlement with St. Louis-based health insurer Centene Corp. to resolve allegations that the company overcharged the state’s Medicaid program for pharmaceutical costs.
Indiana to receive $219M from CVS, Walgreens in opioid settlements
CVS and Walgreens have agreed to pay state and local governments a combined total of more than $10 billion to settle lawsuits over the toll of opioids and now want to know by Dec. 31 whether states are accepting the deals.
Walmart offers to pay $3.1 billion to settle opioid lawsuits
Walmart proposed a $3.1 billion legal settlement Tuesday over the toll of powerful prescription opioids sold at its pharmacies.
CVS, Walgreens announce opioid settlements totaling $10B
CVS Health and Walgreen Co. announced agreements in principle Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids, and a lawyer said Walmart is in discussions for a deal.
Judge rules against required coverage of HIV prevention drug
A federal judge ruled Wednesday that required coverage of an HIV prevention drug under the Affordable Care Act violates a Texas employer’s religious beliefs and undercut the broader system that determines which preventive drugs are covered in the U.S.
Jury orders Lilly to pay $61M in whistleblower Medicaid fraud case
An Illinois jury has ordered Indianapolis-based Eli Lilly and Co. to pay $61 million in damages in a lawsuit filed eight years ago by a whistleblower who said the company made false claims about rebates to the federal Medicaid program.